Find the Perfect Plan for Your Investment Journey
R
Latest price
52 Week Range
R$17.15 - R$30.40
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | R$34.87B |
EV | R$42.06B |
Shares Outstanding | 1.71B |
Beta | 0.24 |
Analyst Rating | HOLD |
Analyst Target Price | R$23.51 |
P/E 2025E | 26.83x |
P/Revenue 2025E | 0.79x |
Revenue | 17.20% |
EPS | 19.30% |
Operating Cash Flow | 21.50% |
Free Cash Flow | 30.00% |
Revenue | 13.80% |
EPS | 16.20% |
Operating Cash Flow | 6.10% |
Free Cash Flow | -7.60% |
Gross Margin 2025E | 28.29% |
Net Profit Margin 2025E | 2.77% |
ROE 2025E | 17.27% |
ROCE 2024 | 19.34% |
DPS 2025E | R$0.31 |
Payout Ratio 2025E | 40.79% |
Div. Yield 2025E | 1.50% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
R
Raia Drogasil S.A.
RADL3
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Pousada, Marcílio
Employees
64,758
Website
rdsaude.com.brIPO Date
2000-01-06
Headquarters
Av. Corifeu de Azevedo Marques, 3.097, ButantA, São Paulo, São Paulo, 05339-900, Brazil
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved